Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinitis | 4 | 2019 | 6 | 1.310 |
Why?
|
| Sinusitis | 4 | 2019 | 11 | 1.310 |
Why?
|
| Endoscopy | 3 | 2023 | 56 | 0.680 |
Why?
|
| Paranasal Sinuses | 2 | 2016 | 6 | 0.630 |
Why?
|
| Hemangioma, Cavernous | 1 | 2019 | 3 | 0.630 |
Why?
|
| Orbital Neoplasms | 1 | 2019 | 11 | 0.620 |
Why?
|
| Palatine Tonsil | 1 | 2017 | 10 | 0.570 |
Why?
|
| Tonsillectomy | 1 | 2017 | 8 | 0.560 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 478 | 0.560 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 31 | 0.550 |
Why?
|
| Olfaction Disorders | 1 | 2015 | 4 | 0.500 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 163 | 0.500 |
Why?
|
| Bell Palsy | 1 | 2015 | 1 | 0.490 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2015 | 6 | 0.490 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2015 | 6 | 0.490 |
Why?
|
| Hemangioma | 1 | 2015 | 8 | 0.490 |
Why?
|
| Propranolol | 1 | 2015 | 39 | 0.490 |
Why?
|
| Eye Abnormalities | 1 | 2015 | 11 | 0.480 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 21 | 0.480 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 79 | 0.470 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 65 | 0.470 |
Why?
|
| Chronic Disease | 4 | 2019 | 273 | 0.300 |
Why?
|
| Nasal Obstruction | 2 | 2018 | 7 | 0.280 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 2021 | 0.270 |
Why?
|
| Adolescent | 6 | 2018 | 3123 | 0.230 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 969 | 0.230 |
Why?
|
| Young Adult | 6 | 2018 | 2731 | 0.230 |
Why?
|
| Humans | 13 | 2023 | 28121 | 0.210 |
Why?
|
| Craniopharyngioma | 1 | 2023 | 14 | 0.210 |
Why?
|
| Aged | 7 | 2018 | 5416 | 0.210 |
Why?
|
| Pituitary Neoplasms | 1 | 2023 | 48 | 0.210 |
Why?
|
| Adenoma | 1 | 2023 | 61 | 0.200 |
Why?
|
| Middle Aged | 8 | 2018 | 7164 | 0.200 |
Why?
|
| Adult | 8 | 2023 | 7757 | 0.200 |
Why?
|
| Treatment Outcome | 5 | 2023 | 2380 | 0.180 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2019 | 8 | 0.160 |
Why?
|
| Delphi Technique | 1 | 2019 | 21 | 0.160 |
Why?
|
| Nasal Surgical Procedures | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 66 | 0.150 |
Why?
|
| Male | 8 | 2018 | 13487 | 0.150 |
Why?
|
| Nasal Septum | 1 | 2018 | 3 | 0.140 |
Why?
|
| Rhinoplasty | 1 | 2018 | 4 | 0.140 |
Why?
|
| Otolaryngology | 1 | 2017 | 8 | 0.140 |
Why?
|
| Female | 8 | 2018 | 15156 | 0.140 |
Why?
|
| Image Cytometry | 1 | 2017 | 2 | 0.140 |
Why?
|
| Monitoring, Immunologic | 1 | 2017 | 7 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2017 | 93 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2017 | 886 | 0.130 |
Why?
|
| Nose Neoplasms | 1 | 2016 | 6 | 0.130 |
Why?
|
| Nasal Cavity | 1 | 2016 | 20 | 0.130 |
Why?
|
| Lymphoma | 1 | 2016 | 26 | 0.130 |
Why?
|
| Age Factors | 1 | 2018 | 733 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2018 | 1249 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 87 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2015 | 67 | 0.120 |
Why?
|
| Hashimoto Disease | 1 | 2015 | 1 | 0.120 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2015 | 5 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 164 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 257 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 475 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 521 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 968 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 406 | 0.110 |
Why?
|
| Eyelid Diseases | 1 | 2013 | 7 | 0.110 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2013 | 4 | 0.110 |
Why?
|
| Orbital Diseases | 1 | 2013 | 7 | 0.110 |
Why?
|
| Blindness | 1 | 2013 | 34 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 270 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 773 | 0.100 |
Why?
|
| Infant | 1 | 2015 | 996 | 0.090 |
Why?
|
| Eye Infections, Bacterial | 1 | 2013 | 123 | 0.090 |
Why?
|
| Quality of Life | 1 | 2015 | 491 | 0.090 |
Why?
|
| United States | 1 | 2017 | 2149 | 0.090 |
Why?
|
| Child | 1 | 2017 | 2242 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2557 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 462 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 1014 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2023 | 53 | 0.050 |
Why?
|
| Nose | 1 | 2023 | 23 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2023 | 115 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2023 | 613 | 0.040 |
Why?
|
| Photography | 1 | 2018 | 19 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 24 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 82 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 44 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 289 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 755 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2015 | 21 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 372 | 0.030 |
Why?
|
| Germinal Center | 1 | 2015 | 21 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 803 | 0.030 |
Why?
|
| Fibrosis | 1 | 2015 | 133 | 0.030 |
Why?
|
| Debridement | 1 | 2013 | 10 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2013 | 35 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 37 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 302 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 83 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 523 | 0.020 |
Why?
|